CHANTER Syndrome: CT and MRI Findings After Drug Exposure
Executive Answer
CHANTER syndrome is a clinical and neuroimaging syndrome described in patients with acute drug exposure and severe impairment of consciousness. Its characteristic imaging pattern centers on restricted diffusion and edema involving the cerebellum, hippocampi, and basal nuclei, often with additional cerebral white-matter involvement.
The most important practical issue is not simply recognizing diffusion restriction. The radiologist must determine where the abnormalities are distributed, whether DWI abnormalities correspond to low ADC, and whether cerebellar edema is threatening the fourth ventricle and cerebrospinal-fluid pathways.
This distinction matters because progressive cerebellar edema can produce fourth-ventricular obstruction, obstructive hydrocephalus, increased intracranial pressure, and potentially life-threatening neurologic deterioration.
CHANTER should therefore be considered when severe altered consciousness after suspected drug exposure is accompanied by bilateral cerebellar abnormalities and multifocal diffusion restriction that does not conform to a single vascular territory.
Why This Case Matters
A patient found unconscious after suspected drug exposure may initially be labeled as having uncomplicated intoxication or hypoxic-ischemic brain injury.
That approach can be dangerous.
The imaging distribution may provide a more specific diagnostic clue. Bilateral cerebellar abnormalities accompanied by abnormalities of the hippocampi and basal nuclei should prompt consideration of CHANTER syndrome, particularly when the lesions do not conform to a conventional arterial distribution.
Another important feature is that severe diffusion restriction does not necessarily mean that the clinical outcome is irreversibly poor. In CHANTER syndrome, management of progressive cerebellar edema and obstructive hydrocephalus may be clinically decisive.
The radiologist therefore has two simultaneous responsibilities:
Recognize the toxic-metabolic imaging pattern.
Identify the posterior fossa complication that may require urgent intervention.
Clinical Scenario
A man in his 30s was found unconscious at home and transported to the emergency department.
He had a history suggesting multiple drug exposure. At presentation, hypertension, tachycardia, and agonal breathing were noted. Intranasal naloxone was administered, but there was only limited improvement in his level of consciousness.
Urine toxicology was positive for:
Amphetamine
Phencyclidine (PCP)
Fentanyl
Delta-9-tetrahydrocannabinol (THC)
The patient remained severely impaired, with minimal response to external stimulation and inability to follow commands.
This clinical setting requires consideration of several possibilities, including drug-related respiratory depression, hypoxic brain injury, acute cerebrovascular disease, and toxic-metabolic encephalopathy.
Importantly, incomplete response to naloxone does not by itself exclude opioid exposure. Multiple substances may have been involved, and secondary hypoxic injury or another neurologic complication may already have occurred.
The central diagnostic principle is therefore:
Toxicology results should be interpreted together with the respiratory status, neurologic examination, and distribution of brain abnormalities on imaging.
What Is CHANTER Syndrome?
CHANTER stands for:
Cerebellar
Hippocampal
And Basal Nuclei
Transient Edema with Restricted Diffusion
CHANTER syndrome describes a clinical and imaging pattern characterized by severe impairment of consciousness after acute drug exposure together with restricted diffusion and edema involving the cerebellum, hippocampi, and basal nuclei.
The syndrome was initially described by Jasne and colleagues in 2019, followed by additional imaging experience reported by Mallikarjun and colleagues in 2022.
Importantly, CHANTER is not diagnosed simply because restricted diffusion is present.
The interpretation requires integration of:
Clinical drug exposure
Severity of altered consciousness
Anatomic distribution of lesions
DWI/ADC correlation
Cerebellar edema
Ventricular and basal cistern status
Relevant differential diagnoses
Why Recognition Is Clinically Important
The most important complication is progressive cerebellar edema.
The posterior fossa is a relatively confined intracranial compartment. Increasing cerebellar volume can compress the fourth ventricle and interfere with cerebrospinal-fluid circulation.
This can result in:
Fourth-ventricular obstruction
Obstructive hydrocephalus
Increased intracranial pressure
Brainstem compression
Neurologic deterioration
Therefore, a CHANTER-pattern MRI should not be treated simply as a diagnostic label.
The radiologist should actively evaluate whether the cerebellar abnormality is producing a mass effect and whether the ventricular system remains patent.
Epidemiology and Clinical Background
CHANTER syndrome is a relatively recently described clinical and imaging pattern. Consequently, robust population-level epidemiologic data are not available.
The published literature has largely consisted of case reports and small case series. Therefore, reliable incidence rates, prevalence estimates, or precise risk percentages for specific age groups or drug exposures cannot currently be established from the available clinical literature.
The clinical background commonly includes:
Acute drug exposure
Possible opioid exposure
Severe impairment of consciousness
Cerebellar, hippocampal, and basal-nuclei abnormalities
Potential progression of cerebellar edema
Possible obstructive hydrocephalus
Clinical presentation and outcome are not uniform. Drug type and exposure, duration and severity of hypoxia, associated disease, and timing of treatment may influence the clinical course.
Pathophysiology
The precise pathophysiology of CHANTER syndrome has not been fully established.
Current discussion includes possible contributions from both direct drug-related neurotoxicity and hypoxic injury associated with respiratory depression.
It would therefore be inappropriate to attribute the syndrome to a single established molecular mechanism.
Direct Neurotoxicity
Opioids and other drugs can affect the central nervous system and alter consciousness and respiratory function.
The selective vulnerability of particular brain structures may reflect direct neurotoxicity or differences in metabolic vulnerability, but the exact mechanism remains uncertain.
Hypoxic Injury and Energy Failure
Severe drug-related respiratory depression may reduce oxygen delivery to the brain.
Energy failure can disrupt cellular ion homeostasis and promote cytotoxic edema. Restricted water movement may then produce increased DWI signal with corresponding ADC reduction.
However, DWI hyperintensity alone does not prove true restricted diffusion.
ADC correlation remains essential because T2 shine-through can produce high DWI signal without equivalent diffusion restriction.
Cerebellar Edema and Hydrocephalus
Cerebellar edema represents a particularly important component of the syndrome.
As cerebellar volume increases, the fourth ventricle and cerebrospinal-fluid pathways may become compressed.
Radiologists should specifically assess:
Fourth-ventricle caliber and patency
Lateral and third ventricular enlargement
Basal cistern patency
Cerebellar mass effect
Brainstem compression
Midline displacement
An initially normal ventricular system does not guarantee that hydrocephalus will not subsequently develop.
Imaging Features
Figure 1. Axial Non-Contrast Brain CT
Caption: Axial non-contrast brain CT demonstrating bilateral cerebellar hypoattenuation.
Radiologic interpretation: Bilateral cerebellar hypoattenuation, particularly involving the cerebellar white matter, is present. No extra-axial hemorrhage is identified, and there is no definite midline shift.
Key diagnostic point: Bilateral cerebellar hypoattenuation may reflect edema or other acute tissue injury. CT alone cannot establish the etiology, but in a patient with suspected drug exposure and severe altered consciousness, a toxic-metabolic encephalopathy including CHANTER syndrome should be considered.
Clinical significance: The fourth ventricle and cerebrospinal-fluid pathways should be evaluated carefully because progressive cerebellar edema may later produce obstructive hydrocephalus.
ALT text: Axial non-contrast brain CT showing bilateral cerebellar hypoattenuation in a patient with suspected toxic-metabolic encephalopathy.
Figure 2. Axial Non-Contrast Brain CT
Caption: Axial non-contrast brain CT demonstrating additional hypoattenuation involving the bilateral lentiform nuclei and left occipital white matter.
Radiologic interpretation: Additional focal hypoattenuation is present in the bilateral lentiform nuclei and left occipital white matter, in association with the bilateral cerebellar abnormalities.
Key diagnostic point: Multiple affected anatomic regions do not conform to a single vascular territory. The combination of cerebellar, deep nuclear, and cerebral white-matter abnormalities is important when considering a toxic-metabolic process.
Clinical significance: CT provides the initial structural assessment, but MRI is required to better characterize lesion distribution and diffusion characteristics.
ALT text: Axial non-contrast brain CT showing bilateral lentiform nucleus and left occipital white-matter hypoattenuation accompanying bilateral cerebellar abnormalities.
MRI Evaluation
MRI is central to the evaluation because it provides information about both lesion distribution and diffusion characteristics.
DWI is sensitive to restricted water movement, ADC helps confirm true diffusion restriction, and FLAIR demonstrates tissue signal abnormality and edema.
The distribution is as important as the signal intensity.
Figure 3. Axial FLAIR MRI
Caption: Axial FLAIR MRI demonstrating relatively symmetric hyperintensity involving the basal nuclei, hippocampi, cerebellum, and cerebral white matter.
Radiologic interpretation: Relatively symmetric FLAIR hyperintensity involves the basal nuclei, hippocampi, cerebellum, and cerebral white matter.
Key diagnostic point: Multifocal bilateral involvement across several anatomic regions is important. FLAIR hyperintensity indicates edema or tissue injury but is not, by itself, specific for CHANTER syndrome.
Clinical significance: The distribution should be correlated with the clinical history of drug exposure and with DWI and ADC findings.
ALT text: Axial FLAIR brain MRI showing bilateral basal nuclei, hippocampal, cerebellar, and cerebral white-matter hyperintensity.
Figure 4. Axial DWI and ADC MRI
Caption: Axial DWI and ADC MRI demonstrating diffusion restriction involving the cerebellum and associated deep structures.
Radiologic interpretation: Multiple regions, including the cerebellum and deep structures, demonstrate signal abnormalities compatible with restricted diffusion.
Key diagnostic point: DWI hyperintensity should be correlated with corresponding ADC hypointensity to confirm true diffusion restriction.
Clinical significance: Multifocal restricted diffusion should not immediately be interpreted as widespread irreversible ischemic injury. The anatomic distribution and clinical setting must be considered.
ALT text: Axial DWI and ADC MRI demonstrating restricted diffusion in the cerebellum and deep gray matter structures.
Figure 5. Axial DWI and ADC MRI
Caption: Axial DWI and ADC MRI demonstrating bilateral hippocampal involvement.
Radiologic interpretation: The images demonstrate bilateral hippocampal involvement. In the overall MRI examination, the hippocampi show diffusion restriction and corresponding FLAIR hyperintensity.
Key diagnostic point: Bilateral hippocampal abnormalities can occur in opioid-associated amnestic syndrome as well as other toxic or hypoxic conditions. Hippocampal involvement alone is therefore insufficient to establish CHANTER syndrome.
Clinical significance: The hippocampal abnormalities should be interpreted together with the cerebellar and basal-nuclei involvement.
ALT text: Axial DWI and ADC MRI showing bilateral hippocampal diffusion abnormality in a patient with suspected CHANTER syndrome.
Figure 6. Axial DWI and ADC MRI
Caption: Axial DWI and ADC MRI demonstrating diffusion restriction involving the basal nuclei.
Radiologic interpretation: Diffusion restriction is demonstrated in the deep gray matter, including the basal nuclei. Bilateral basal-nuclei involvement is present in the overall examination.
Key diagnostic point: Symmetric basal-nuclei involvement can occur in toxic-metabolic and hypoxic injury and is not specific to CHANTER syndrome.
Clinical significance: The basal-nuclei findings become more diagnostically meaningful when interpreted together with the cerebellar and hippocampal abnormalities and the clinical drug-exposure history.
ALT text: Axial DWI and ADC MRI demonstrating bilateral basal-nuclei diffusion restriction.
Figure 7. Axial DWI and ADC MRI
Caption: Axial DWI and ADC MRI demonstrating multifocal diffusion abnormality involving the cerebral white matter.
Radiologic interpretation: Multifocal cerebral white-matter abnormalities are evaluated for diffusion restriction. In the overall case, cerebral white matter also demonstrates FLAIR hyperintensity and diffusion restriction.
Key diagnostic point: White-matter involvement requires consideration of heroin-associated spongiform leukoencephalopathy and other toxic white-matter disorders.
Clinical significance: White-matter abnormalities should not be interpreted in isolation. The relative involvement of gray matter and white matter, symmetry, exposure history, and accompanying cerebellar, hippocampal, and basal-nuclei abnormalities should all be considered.
ALT text: Axial DWI and ADC MRI showing multifocal cerebral white-matter diffusion abnormalities in a toxic-metabolic brain injury pattern.
Figure 8. Axial Post-Contrast T1-Weighted MRI
Caption: Axial post-contrast T1-weighted MRI demonstrating subtle gyriform enhancement in portions of the cerebellum.
Radiologic interpretation: Subtle gyriform enhancement is present in portions of the cerebellum. Mild cerebral hemispheric edema is also present. There is no midline shift, and the basal cisterns remain open.
Key diagnostic point: CHANTER syndrome may demonstrate absent or limited enhancement. The presence of limited enhancement does not exclude the diagnosis.
Clinical significance: Enhancement should not be used as the primary discriminator. The DWI, ADC, and FLAIR distribution, cerebellar edema, ventricular configuration, and basal cisterns must be evaluated together.
ALT text: Axial post-contrast T1-weighted brain MRI showing subtle cerebellar gyriform enhancement with mild cerebral edema.
MRI Interpretation Checklist
When reviewing a suspected CHANTER case, the following imaging elements should be assessed systematically:
DWI: Distribution of hyperintense lesions and possible restricted diffusion.
ADC: Corresponding low signal confirming true diffusion restriction.
FLAIR: Extent and distribution of edema and tissue injury.
Post-contrast T1: Presence and pattern of enhancement.
Overall anatomy: Fourth ventricle, lateral and third ventricles, basal cisterns, cerebellar mass effect, and brainstem compression.
The critical interpretive principle is that the radiologist should not focus only on which structures are bright.
The important questions are:
Where are the lesions? Are they symmetric? Is the diffusion restriction real? Is the fourth ventricle patent? Are the basal cisterns open?
Differential Diagnosis
CHANTER syndrome overlaps with several acute neurologic conditions. Restricted diffusion is not specific and can occur in acute ischemic stroke, hypoxic injury, toxic-metabolic encephalopathy, and other disorders.
Acute Ischemic Stroke
Acute infarction generally demonstrates a distribution compatible with a vascular territory or identifiable arterial occlusion.
DWI hyperintensity with ADC reduction is common in acute infarction, but the overall distribution should be considered.
In CHANTER syndrome, abnormalities may involve multiple anatomic regions in a relatively symmetric pattern that does not correspond to one vascular territory.
If acute stroke remains clinically plausible, CT angiography or MR angiography may be appropriate.
Hypoxic-Ischemic Encephalopathy
Hypoxic-ischemic injury may occur after respiratory arrest, cardiac arrest, or severe systemic hypoxia.
The cerebral cortex and deep gray matter can demonstrate restricted diffusion.
CHANTER syndrome may coexist with or be influenced by hypoxic injury because drug-related respiratory depression can reduce oxygen delivery.
Therefore, CHANTER and hypoxic-ischemic injury should not always be treated as mutually exclusive mechanisms.
Heroin-Associated Spongiform Leukoencephalopathy
Heroin-associated spongiform leukoencephalopathy is a toxic white-matter disorder associated with particular patterns of heroin exposure.
Symmetric white-matter abnormalities, including cerebellar white-matter involvement, may occur.
The distinction depends on whether the abnormalities are predominantly white matter, whether gray-matter structures such as the hippocampi and basal nuclei are involved, the exposure route, and the clinical presentation.
Opioid-Associated Amnestic Syndrome
Opioid-associated amnestic syndrome is characterized primarily by acute amnesia and bilateral hippocampal abnormalities.
Hippocampal involvement can also occur in CHANTER syndrome.
The combination of severe altered consciousness, cerebellar and basal-nuclei involvement, and potentially dangerous cerebellar edema should therefore prompt consideration of CHANTER rather than diagnosing opioid-associated amnestic syndrome based on hippocampal abnormalities alone.
Posterior Reversible Encephalopathy Syndrome
PRES commonly produces vasogenic edema involving posterior cerebral regions, although atypical distributions can occur.
Hypertension and other relevant clinical conditions may provide supportive context.
However, posterior location alone should not lead to a diagnosis of PRES. Diffusion characteristics, the distribution of abnormalities, cerebellar involvement, hippocampal and basal-nuclei abnormalities, and the drug-exposure history should all be considered.
Treatment and Emergency Management
Management of CHANTER syndrome is not based on a single disease-specific medication.
Initial priorities include:
Airway assessment and stabilization
Adequate oxygenation and ventilation
Circulatory stabilization
Correction of hypoglycemia and metabolic abnormalities
Assessment for coexisting trauma or other causes of altered consciousness
Evaluation for suspected opioid toxicity when appropriate
Naloxone may be administered when opioid exposure is suspected, but incomplete recovery after naloxone should prompt continued evaluation for other toxic, hypoxic, or structural brain injury.
Cerebellar Edema Requires Close Monitoring
Patients with substantial cerebellar edema require close neurologic and imaging surveillance.
Important warning signs include:
Fourth-ventricular compression or obstruction
Enlargement of the lateral or third ventricles
Loss of basal cisterns
Brainstem compression
Declining level of consciousness
Progressive edema on follow-up imaging
In an appropriate clinical setting, intensive-care monitoring and measures for cerebral edema may be required.
If obstructive hydrocephalus develops, urgent neurosurgical evaluation may be necessary. External ventricular drainage or decompressive surgery should be determined according to the patient's anatomy, clinical status, and institutional management strategy.
Not every patient requires surgery.
However, progressive ventricular enlargement or brainstem compression should not be managed by passive observation alone.
Prognosis
The initial MRI can appear alarming because patients may have severe impairment of consciousness and extensive diffusion abnormalities.
Nevertheless, reported CHANTER cases demonstrate that substantial recovery can occur in some patients, particularly when cerebellar edema and hydrocephalus are recognized and appropriately managed.
This does not mean that the prognosis is uniformly favorable.
Outcome may be influenced by:
Type and extent of drug exposure
Severity and duration of hypoxia
Progression of cerebellar edema
Development of hydrocephalus
Timing of treatment
Associated brain injury
Neurologic recovery during follow-up
Imaging recovery and functional recovery may not occur at the same rate.
Patients may have persistent cognitive, memory, gait, or balance abnormalities even when acute imaging abnormalities improve.
Radiologist's Diagnostic Checklist
Step 1 — Establish the Clinical Context
Ask whether there is:
Suspected drug exposure
Respiratory depression
Hypoxia
Severe altered consciousness
Step 2 — Review Non-Contrast CT
Evaluate:
Hemorrhage
Cerebellar hypoattenuation
Deep nuclear abnormalities
Fourth ventricle
Ventricular system
Basal cisterns
Step 3 — Compare DWI and ADC
Determine whether DWI hyperintensity corresponds to ADC hypointensity.
Do not diagnose restricted diffusion from DWI alone.
Step 4 — Map the FLAIR Distribution
Specifically assess:
Cerebellum
Hippocampi
Basal nuclei
Cerebral white matter
Evaluate symmetry and overall distribution.
Step 5 — Evaluate Enhancement and Additional Imaging
Assess post-contrast T1 imaging when available and clinically indicated.
If acute ischemic stroke remains a possibility, vascular imaging may be appropriate.
Step 6 — Assess for Hydrocephalus
Evaluate:
Fourth-ventricular obstruction
Ventricular enlargement
Basal cistern compression
Brainstem compression
Posterior fossa mass effect
Step 7 — Integrate Clinical and Imaging Information
The final interpretation should consider CHANTER syndrome, hypoxic-ischemic injury, acute ischemic stroke, heroin-associated spongiform leukoencephalopathy, opioid-associated amnestic syndrome, and PRES as appropriate.
This checklist is an aid to systematic interpretation. It is not an automatic diagnostic rule.
Diagnostic Risks and Common Pitfalls
Pitfall 1: Calling the Case Simple Drug Intoxication
A positive toxicology test does not explain the entire neurologic presentation.
Better approach: Determine whether structural brain abnormalities are present.
Pitfall 2: Assuming All Diffusion Restriction Represents Irreversible Hypoxic Injury
Diffuse diffusion restriction can be alarming, but distribution matters.
Better approach: Evaluate the cerebellum, hippocampi, basal nuclei, white matter, cortex, and vascular territories together.
Pitfall 3: Ignoring ADC
DWI hyperintensity alone can be misleading.
Better approach: Confirm true restriction with ADC.
Pitfall 4: Focusing Only on the Cerebral Hemispheres
The posterior fossa may contain the most immediately dangerous abnormality.
Better approach: Always evaluate cerebellar swelling and the fourth ventricle.
Pitfall 5: Assuming No Midline Shift Means No Emergency
Posterior fossa deterioration can occur without a large supratentorial midline shift.
Better approach: Evaluate the fourth ventricle, basal cisterns, ventricles, and brainstem.
Pitfall 6: Diagnosing Opioid-Associated Amnestic Syndrome From Hippocampal Abnormalities Alone
Bilateral hippocampal involvement is not specific.
Better approach: Determine whether cerebellar and basal-nuclei abnormalities are also present.
Clinical AI Perspective
CHANTER syndrome illustrates an important challenge for clinical AI: rare-pattern recognition in a high-acuity environment.
An AI system could potentially assist by identifying combinations of imaging findings rather than searching for a single abnormal structure.
Potential applications include:
Automated detection of bilateral cerebellar abnormalities
Detection of symmetric basal-nuclei abnormalities
Identification of hippocampal involvement
DWI/ADC mismatch or concordance analysis
Quantification of cerebellar edema
Detection of fourth-ventricular compression
Automated hydrocephalus alerts
Comparison of serial CT or MRI examinations
Worklist prioritization for potentially critical posterior fossa findings
However, these applications should be considered potential workflow functions rather than established clinical performance claims.
Because CHANTER is uncommon, large representative datasets may be difficult to assemble. A model trained predominantly on common stroke or hypoxic injury patterns may have difficulty distinguishing a rare toxic-metabolic distribution.
AI Limitations
Potential AI failure modes include:
Limited representation of rare CHANTER cases
Dataset imbalance
Scanner and protocol variation
Domain shift between hospitals
Motion artifact in critically ill patients
Difficulty distinguishing overlapping toxic and hypoxic patterns
False-positive alerts for common diffusion abnormalities
False-negative recognition of subtle cerebellar edema
Failure to appreciate clinical toxicology context
Alert fatigue
AI should therefore support—not replace—the radiologist's clinical reasoning.
The final interpretation still requires correlation with exposure history, respiratory status, neurologic examination, laboratory data, imaging distribution, and serial change.
Enterprise Imaging and Clinical Workflow
A realistic AI-assisted workflow could be represented as:
For CHANTER-like cases, the highest-value workflow contribution may not be automated diagnosis.
It may be early recognition of a potentially dangerous posterior fossa abnormality and prioritization of the examination for radiologist review.
A clinically useful system would ideally integrate:
DWI/ADC analysis
Cerebellar edema assessment
Ventricular measurements
Serial imaging comparison
Critical-result communication
PACS visualization
The radiologist remains responsible for determining whether the complete clinical and imaging pattern is compatible with CHANTER syndrome or another diagnosis.
Healthcare-System Implications
Although CHANTER syndrome is rare, the clinical consequences of delayed recognition can be substantial.
A workflow that reliably identifies cerebellar edema and evolving hydrocephalus could potentially support earlier communication among:
Emergency physicians
Radiologists
Neurologists
Neurosurgeons
Critical-care teams
The value of imaging AI in this setting should therefore be considered in terms of clinical workflow and time-to-recognition, not simply algorithmic classification accuracy.
No specific AI sensitivity, specificity, time-saving effect, or economic benefit should be assumed unless validated in an appropriate clinical study.
Frequently Asked Questions
What is CHANTER syndrome on MRI?
CHANTER syndrome is characterized by a clinical and imaging pattern involving restricted diffusion and edema, particularly affecting the cerebellum, hippocampi, and basal nuclei in the setting of acute drug exposure and severe altered consciousness.
What are the key MRI findings of CHANTER syndrome?
The key pattern includes cerebellar, hippocampal, and basal-nuclei involvement with restricted diffusion. Additional cerebral white-matter abnormalities may occur.
Does DWI hyperintensity prove restricted diffusion?
No. DWI should be correlated with ADC. Corresponding ADC reduction supports true restricted diffusion.
What is the most dangerous complication of CHANTER syndrome?
Progressive cerebellar edema can compress the fourth ventricle and cause obstructive hydrocephalus and increased intracranial pressure.
Can CHANTER syndrome be confused with hypoxic-ischemic brain injury?
Yes. Both conditions can produce multifocal diffusion restriction. Clinical history, lesion distribution, severity of hypoxia, and posterior fossa findings must be integrated.
Can CHANTER syndrome have contrast enhancement?
Limited enhancement may occur. The presence of subtle enhancement does not by itself exclude CHANTER syndrome.
Is CHANTER syndrome associated with opioid exposure?
Opioid exposure has been reported frequently in the clinical context of CHANTER syndrome, but toxicology and imaging findings should be interpreted together rather than treating a single drug result as diagnostic.
Why is the cerebellum so important?
Progressive cerebellar edema can obstruct the fourth ventricle and produce obstructive hydrocephalus, making the posterior fossa finding an immediate management concern.
Educational Quiz
Question 1 — CT Interpretation
A man in his 30s is found unconscious after suspected drug exposure. Urine testing is positive for fentanyl and multiple substances. Non-contrast CT demonstrates bilateral cerebellar hypoattenuation with additional hypoattenuation in the bilateral lentiform nuclei and left occipital white matter. There is no midline shift or extra-axial hemorrhage.
What is the most appropriate interpretation?
A. Typical right middle cerebral artery infarction
B. Isolated bilateral cerebral white-matter disease
C. Multifocal hypoattenuation involving the cerebellum and deep nuclei, requiring consideration of toxic-metabolic encephalopathy including CHANTER syndrome
D. Confirmed obstructive hydrocephalus
E. Extra-axial hemorrhage with midline shift
Answer: C
The distribution is not confined to a single vascular territory. In the setting of drug exposure and severe altered consciousness, toxic-metabolic encephalopathy including CHANTER syndrome should be considered.
Question 2 — Next Imaging Study
A patient remains severely impaired after suspected drug intoxication. CT demonstrates bilateral cerebellar and deep-nuclear hypoattenuation.
What is the most appropriate next imaging study?
A. Carotid Doppler ultrasound alone
B. Contrast-enhanced neck CT alone
C. Brain MRI including DWI, ADC, and FLAIR, with additional pre- and post-contrast T1-weighted imaging when clinically indicated
D. Skull radiography
E. No further imaging
Answer: C
DWI and ADC evaluate diffusion restriction, while FLAIR helps characterize edema and lesion distribution. Contrast-enhanced T1-weighted imaging can be added when clinically indicated.
Question 3 — MRI Pattern
A patient with suspected opioid exposure demonstrates relatively symmetric diffusion restriction and FLAIR hyperintensity involving the bilateral cerebellum, hippocampi, basal nuclei, and cerebral white matter. Subtle cerebellar gyriform enhancement is present. The basal cisterns are open, and there is no midline shift.
What is the most appropriate interpretation?
A. CHANTER syndrome is excluded because enhancement is present.
B. Opioid-associated amnestic syndrome is confirmed because the hippocampi are involved.
C. CHANTER syndrome should be considered based on the overall clinical and imaging pattern.
D. Multiple acute ischemic strokes are confirmed.
E. Cerebellar edema requires no further evaluation because there is no midline shift.
Answer: C
The combination of drug exposure, severe altered consciousness, cerebellar, hippocampal, and basal-nuclei involvement, and multifocal diffusion restriction supports consideration of CHANTER syndrome. Limited enhancement does not exclude the diagnosis, and absence of midline shift does not eliminate the risk of progressive posterior fossa complications.
Key Takeaways
Think beyond intoxication. Severe altered consciousness after drug exposure with structural brain abnormalities requires further evaluation.
Distribution matters. Cerebellar, hippocampal, and basal-nuclei involvement is the central imaging pattern.
Confirm diffusion restriction. Always correlate DWI with ADC.
Do not ignore the cerebellum. Posterior fossa edema may become the most urgent finding.
Check the fourth ventricle. Cerebellar swelling can cause obstructive hydrocephalus.
Consider the differential diagnosis. Acute ischemic stroke, hypoxic-ischemic injury, heroin-associated spongiform leukoencephalopathy, opioid-associated amnestic syndrome, and PRES may overlap.
Do not overinterpret enhancement. Limited cerebellar enhancement does not exclude CHANTER syndrome.
Do not assume prognosis from diffusion restriction alone. Clinical course and management of cerebellar edema are important.
AI may assist recognition and prioritization, but it cannot replace clinical-radiologic integration.
The most important radiologic question is not simply “What is the diagnosis?” but also “Is the posterior fossa becoming dangerous?”
Conclusion
CHANTER syndrome is an important toxic-metabolic neuroimaging pattern that should be considered in patients with acute drug exposure, severe impairment of consciousness, and multifocal diffusion abnormalities.
On CT, bilateral cerebellar hypoattenuation with associated deep-nuclear abnormalities can provide an early clue.
On MRI, the combination of cerebellar, hippocampal, and basal-nuclei abnormalities with restricted diffusion is particularly important. DWI findings should always be correlated with ADC, while FLAIR helps define the extent and distribution of edema.
The most clinically important issue is the posterior fossa.
Progressive cerebellar edema may compress the fourth ventricle and produce obstructive hydrocephalus, increased intracranial pressure, and neurologic deterioration. Consequently, ventricular configuration, basal cisterns, cerebellar mass effect, and brainstem compression should be assessed deliberately.
CHANTER syndrome should therefore be approached as both a diagnostic pattern and a potential neurologic emergency.
The radiologist's role is not simply to recognize the acronym. It is to integrate the clinical history, toxicology, CT findings, MRI distribution, diffusion characteristics, differential diagnosis, and posterior fossa complications into a clinically actionable interpretation.
Suggested Related Reading
For readers continuing this topic, useful next reading areas include:
Medical Disclaimer
This article is provided for medical education and informational purposes only. It does not replace professional medical diagnosis, treatment, or consultation. Individual patients should be evaluated by qualified healthcare professionals using their complete clinical history, examination, laboratory data, and imaging findings.
References
Jasne AS, Alsherbini KH, Smith MS, Pandhi A, Vagal A, Kanter D. Cerebellar hippocampal and basal nuclei transient edema with restricted diffusion (CHANTER) syndrome. Neurocritical Care. 2019;31(2):288–296. https://doi.org/10.1007/s12028-018-00666-4
Mallikarjun KS, Parsons MS, Nigogosyan Z, Goyal MS, Eldaya RW. Neuroimaging findings in CHANTER syndrome: A case series. American Journal of Neuroradiology. 2022;43(8):1136–1141. https://doi.org/10.3174/ajnr.A7569
Hiana J, Soh J, Marchidann A. CHANTER syndrome: A rare cause of encephalopathy and ischemic lesions. Neurology. 2023;100(17 Suppl 2):2892. https://doi.org/10.1212/WNL.0000000000202872
Bach AG, Jordan B, Wegener NA, Rusner C, Kornhuber M, Abbas J, Surov A. Heroin spongiform leukoencephalopathy (HSLE). Clinical Neuroradiology. 2012;22(4):345–349. https://doi.org/10.1007/s00062-012-0173-y
Barash JA, et al. Opioid-associated amnestic syndrome: Description of the syndrome and validation of a proposed definition. Journal of the Neurological Sciences. 2020;417:117048. https://doi.org/10.1016/j.jns.2020.117048
Wei R, et al. Prediction of poor outcome after hypoxic-ischemic brain injury by diffusion-weighted imaging: A systematic review and meta-analysis. PLOS ONE. 2019;14(12). https://doi.org/10.1371/journal.pone.0226295
Chang WC, Lo CP, Kao HW, Chen CY. MRI features of spongiform leukoencephalopathy following heroin inhalation. Neurology. 2006;67(3):504. https://doi.org/10.1212/01.wnl.0000216155.52411.6e
Bega DS, McDaniel LM, Jhaveri MD, Lee VH. Diffusion weighted imaging in heroin-associated spongiform leukoencephalopathy. Neurocritical Care. 2009;10(3):352–354. https://doi.org/10.1007/s12028-008-9172-x
Finsterer J, Mehri S. Before diagnosing CHANTER syndrome, all possible differential diagnoses must be carefully excluded. Korean Journal of Radiology. 2024;25(6):589–590. https://doi.org/10.3348/kjr.2024.0244
Comments
Post a Comment